Incidence and risk factors for non-alcoholic steatohepatitis: Prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial

British Medical Journal

Volumn 330, Issue 7497, 2005, Pages 932-935

  Bruno, Savino ^a   Maisonneuve, Patrick ^b   Castellana, Paola ^b   Rotmensz, Nicole ^b   Rossi, Sonia ^b   Maggioni, Marco ^b   Persico, Marcello ^b   Colombo, Alberto ^b   Monasterolo, Franco ^b   Casadei Giunchi, Donata ^b   Desiderio, Franco ^b   Straffolini, Tommaso ^b   Sacchini, Virgilio ^b   Decensi, Andrea ^b   Veronesi, Umberto ^b  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; PLACEBO; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FATTY LIVER; FEMALE; FOLLOW UP; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYSTERECTOMY; INCIDENCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; OBESITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIDE EFFECT; AGED; BIOPSY; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; ITALY; LIVER; METHODOLOGY; MIDDLE AGED; PATHOLOGY; TOXIC HEPATITIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY; BREAST NEOPLASMS; DOUBLE-BLIND METHOD; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, TOXIC; HUMANS; INCIDENCE; ITALY; LIVER; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TAMOXIFEN;

EID: 20244370881     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38391.663287.E0     Document Type: Article

References (14)

1. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 1998;90:1371-88.
2. Pratt DS, Knox TA, Erban J. Tamoxifen induced steatohepatitis. Ann Intern Med 1995;123:236.
3. Van Hoof M, Rahier J, Horsmans Y. Tamoxifen-induced steatohepatitis. Ann Intern Med 1996;124:855-6.
4. Oien KA, Moffat D, Curry GW, Dickson J, Habeshaw T, Mills PR, et al. Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet 1999;353:36-7.
5. Veronesi U, Maisonneuve P, Costa A, Sacchini V, Maltoni C, Robertson C, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet 1998;352:93-7.
6. Veronesi U. Prevention of breast cancer with tamoxifen: the Italian study in hysterectomized women. The Breast 1995;4:267-72.
7. Van Ness MM, Diehl AM. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 1989;111:473-8.
8. Nishino M, Hayakawa K, Nakamura Y, Morimoto T, Mukaihara S. Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy. Am J Roentgenol 2003;180:129-34.
9. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:113-7.
10. Clark JM, Brancati FL, Diehl AM. Non-alcoholic fatty liver disease. Gastroenterology 2002;122:1649-57.
11. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Crucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-40.
12. Powell EE, Cooksley GE, Hanson R, Searle J, Halliday JW Powell LW. The natural history of nonalcoholic steatohepatitis: a follow up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
13. Adams LA, Keach J, Lindor KD, Angulo P. Time course of fibrosis progression in patients with non alcoholic fatty liver disease. Hepatology 2003;38:104.
14. Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, et al. Frequency of non-alcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 2001;7:608-14.